ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.45
+0.86 (3.23%)
Nov 22, 2024, 4:00 PM EST - Market closed

ArriVent BioPharma Analyst Ratings

Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$36.80
Upside
+34.06%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$36
Strong Buy Reiterates $36 +31.15% Nov 15, 2024
Citigroup
Citigroup
Strong Buy
Maintains
$30$36
Strong Buy Maintains $30$36 +31.15% Sep 11, 2024
Oppenheimer
Oppenheimer
Buy
Reiterates
$35$39
Buy Reiterates $35$39 +42.08% Sep 10, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$28$38
Strong Buy Maintains $28$38 +38.43% Sep 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$30$36
Strong Buy Maintains $30$36 +31.15% Sep 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$25$30
Strong Buy Maintains $25$30 +9.29% Aug 16, 2024
Oppenheimer
Oppenheimer
Buy
Reiterates
$35
Buy Reiterates $35 +27.50% Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$25
Strong Buy Reiterates $25 -8.93% Jun 6, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$25
Strong Buy Reiterates $25 -8.93% May 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$25
Strong Buy Initiates $25 -8.93% Apr 30, 2024
Citigroup
Citigroup
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +9.29% Feb 20, 2024
Jefferies
Jefferies
Strong Buy
Initiates
$35
Strong Buy Initiates $35 +27.50% Feb 20, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Initiates
$27
Strong Buy Initiates $27 -1.64% Feb 20, 2024